Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
Ionis Pharmaceuticals (IONS) Ownership - Who Owns Ionis Pharmaceuticals?
1,255 Followers
Ionis Pharmaceuticals (IONS) Ownership Overview
2.96% Insiders
38.16% Mutual Funds
49.83% Other Institutional Investors
9.05% Public Companies and
Individual Investors
The ownership structure of Ionis Pharmaceuticals (IONS) stock is a mix of institutional, retail and individual investors. Approximately 87.99% of the company’s stock is owned by Institutional Investors, 2.96% is owned by Insiders and 9.05% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 20, 2024 | Spencer Berthelsen Director | Sold | $644640 |
| May 07, 2024 | Joseph Klein Director | Sold | $256243 |
| Feb 16, 2024 | Brett Monia Ceo Level 15,director | Sold | $17218 |
| Feb 02, 2024 | Eric Swayze Officer Level 14 | Sold | $560196 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Sold | $3294 | |
| Mar 31, 2024 | Sold | $294173 | |
| Mar 31, 2024 | Bought | $1323952 | |
| Mar 31, 2024 | Sold | $31818900 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,688,421 | Institution | 8.01% | 550,641,513 | |
| 11,312,657 | Institution | 7.75% | 532,939,271 | |
| 11,060,571 | Institution | 7.58% | 521,063,500 | |
| 4,705,900 | Institution | 3.22% | 221,694,949 | |
| 4,177,178 | Institution | 2.86% | 196,786,856 | |
| 3,591,680 | Institution | 2.46% | 169,204,045 | |
| 3,454,676 | Institution | 2.37% | 162,749,786 | |
| 2,954,743 | Institution | 2.02% | 139,197,943 | |
| 2,335,501 | Institution | 1.60% | 110,025,452 | |
| 1,815,458 | Institution | 1.24% | 85,526,226 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,312,657 | Institution | 7.75% | 532,939,271 | |
| 11,060,571 | Institution | 7.58% | 521,063,500 | |
| 4,705,900 | Institution | 3.22% | 221,694,949 | |
| 3,591,680 | Institution | 2.46% | 169,204,045 | |
| 2,954,743 | Institution | 2.02% | 139,197,943 | |
| 2,335,501 | Institution | 1.60% | 110,025,452 | |
| 1,655,237 | Institution | 1.13% | 77,978,215 | |
| 1,447,053 | Institution | 0.99% | 68,170,667 | |
| 1,293,209 | Institution | 0.89% | 60,923,076 | |
| 1,146,871 | Institution | 0.79% | 54,029,093 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,929,278 | Institution | 2.69% | 147,622,974 | |
| 3,161,663 | Institution | 2.17% | 118,783,679 | |
| 1,747,359 | Institution | 1.20% | 83,279,130 | |
| 2,163,015 | Institution | 1.48% | 81,264,474 | |
| 1,795,632 | Institution | 1.23% | 67,461,894 | |
| 1,345,634 | Institution | 0.92% | 63,392,818 | |
| 995,306 | Institution | 0.68% | 46,888,866 | |
| 740,733 | Institution | 0.51% | 34,895,932 | |
| 684,731 | Institution | 0.47% | 32,634,279 | |
| 486,404 | Institution | 0.33% | 22,914,492 |
FAQ
Who Owns Ionis Pharmaceuticals (IONS)?
According to the latest TipRanks data, approximately 49.83% of the company's stock is held by institutional investors, 2.96% is held by insiders, and 9.05% is held by retail investors.
What percentage of Ionis Pharmaceuticals (IONS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 49.83% of Ionis Pharmaceuticals (IONS) stock is held by institutional investors.
What percentage of Ionis Pharmaceuticals (IONS) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.05% of Ionis Pharmaceuticals (IONS) stock is held by retail investors.
Who owns the most shares of Ionis Pharmaceuticals (IONS)?
Vanguard owns the most shares of Ionis Pharmaceuticals (IONS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.